GB0704846D0 - Topical pharmaceutical formulation - Google Patents

Topical pharmaceutical formulation

Info

Publication number: GB0704846D0
Authority: GB; United Kingdom
Prior art keywords: pharmaceutical formulation; topical pharmaceutical; topical; formulation; pharmaceutical
Prior art date: 2007-03-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0704846.5A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

FUTURA MEDICAL DEV Ltd

Original Assignee

FUTURA MEDICAL DEV Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-03-13

Filing date

2007-03-13

Publication date

2007-04-18

2007-03-13 Application filed by FUTURA MEDICAL DEV Ltd filed Critical FUTURA MEDICAL DEV Ltd

2007-03-13 Priority to GBGB0704846.5A priority Critical patent/GB0704846D0/en

2007-04-18 Publication of GB0704846D0 publication Critical patent/GB0704846D0/en

2008-02-15 Priority to BRPI0808887-0A priority patent/BRPI0808887A2/en

2008-02-15 Priority to DK08709428.0T priority patent/DK2131813T3/en

2008-02-15 Priority to NZ579895A priority patent/NZ579895A/en

2008-02-15 Priority to EP12154983A priority patent/EP2452671A2/en

2008-02-15 Priority to RU2009136228/15A priority patent/RU2468794C2/en

2008-02-15 Priority to MYPI20093774A priority patent/MY149545A/en

2008-02-15 Priority to PL08709428T priority patent/PL2131813T3/en

2008-02-15 Priority to CA2680074A priority patent/CA2680074C/en

2008-02-15 Priority to JP2009553196A priority patent/JP2010521442A/en

2008-02-15 Priority to SG2012017497A priority patent/SG179480A1/en

2008-02-15 Priority to AU2008224735A priority patent/AU2008224735B2/en

2008-02-15 Priority to PT08709428T priority patent/PT2131813E/en

2008-02-15 Priority to ES08709428T priority patent/ES2391914T3/en

2008-02-15 Priority to UAA200910111A priority patent/UA100509C2/en

2008-02-15 Priority to EP08709428A priority patent/EP2131813B1/en

2008-02-15 Priority to CN200880007936A priority patent/CN101663022A/en

2008-02-15 Priority to MX2009009758A priority patent/MX2009009758A/en

2008-02-15 Priority to PCT/GB2008/000540 priority patent/WO2008110741A2/en

2008-02-15 Priority to US12/530,960 priority patent/US8541470B2/en

2008-02-20 Priority to TW097105840A priority patent/TWI367110B/en

2009-10-08 Priority to CO09111579A priority patent/CO6220926A2/en

Status Ceased legal-status Critical Current

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
230000000699 topical effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Pain & Pain Management (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dermatology (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GBGB0704846.5A 2007-03-13 2007-03-13 Topical pharmaceutical formulation Ceased GB0704846D0 (en)

Priority Applications (22)

Application Number	Priority Date	Filing Date	Title
GBGB0704846.5A GB0704846D0 (en)	2007-03-13	2007-03-13	Topical pharmaceutical formulation
US12/530,960 US8541470B2 (en)	2007-03-13	2008-02-15	Topical pharmaceutical formulation
SG2012017497A SG179480A1 (en)	2007-03-13	2008-02-15	Topical pharmaceutical formulation
PT08709428T PT2131813E (en)	2007-03-13	2008-02-15	Topical pharmaceutical formulation
NZ579895A NZ579895A (en)	2007-03-13	2008-02-15	Topical pharmaceutical formulation
EP12154983A EP2452671A2 (en)	2007-03-13	2008-02-15	Topical Pharmaceutical Formulation
RU2009136228/15A RU2468794C2 (en)	2007-03-13	2008-02-15	Pharmaceutical composition for topic application
MYPI20093774A MY149545A (en)	2007-03-13	2008-02-15	Topical single phase pharmaceutical formulation containing diclofenac, ketorolac or ketoprofen
PL08709428T PL2131813T3 (en)	2007-03-13	2008-02-15	Topical pharmaceutical formulation
CA2680074A CA2680074C (en)	2007-03-13	2008-02-15	Topical pharmaceutical formulation
JP2009553196A JP2010521442A (en)	2007-03-13	2008-02-15	Topical formulation
BRPI0808887-0A BRPI0808887A2 (en)	2007-03-13	2008-02-15	TOPICAL PHARMACEUTICAL FORMULATION
AU2008224735A AU2008224735B2 (en)	2007-03-13	2008-02-15	Topical pharmaceutical formulation
DK08709428.0T DK2131813T3 (en)	2007-03-13	2008-02-15	Topical pharmaceutical formulations
ES08709428T ES2391914T3 (en)	2007-03-13	2008-02-15	Topical pharmaceutical formulation
UAA200910111A UA100509C2 (en)	2007-03-13	2008-02-15	Pharmaceutical formulation for topical application of nsaid
EP08709428A EP2131813B1 (en)	2007-03-13	2008-02-15	Topical pharmaceutical formulation
CN200880007936A CN101663022A (en)	2007-03-13	2008-02-15	Topical pharmaceutical formulations
MX2009009758A MX2009009758A (en)	2007-03-13	2008-02-15	Topical pharmaceutical formulation.
PCT/GB2008/000540 WO2008110741A2 (en)	2007-03-13	2008-02-15	Topical pharmaceutical formulation
TW097105840A TWI367110B (en)	2007-03-13	2008-02-20	Topical pharmaceutical formulation
CO09111579A CO6220926A2 (en)	2007-03-13	2009-10-08	TOPIC PHARMACEUTICAL FORMULATION FOR THE APPLICATION OF AN NON-SPHERIDAL ANTI-INFLAMMATORY PHARMACO (NSAID)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0704846.5A GB0704846D0 (en)	2007-03-13	2007-03-13	Topical pharmaceutical formulation

Publications (1)

Publication Number	Publication Date
GB0704846D0 true GB0704846D0 (en)	2007-04-18

Family

ID=37988913

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB0704846.5A Ceased GB0704846D0 (en)	2007-03-13	2007-03-13	Topical pharmaceutical formulation

Country Status (21)

Country	Link
US (1)	US8541470B2 (en)
EP (2)	EP2452671A2 (en)
JP (1)	JP2010521442A (en)
CN (1)	CN101663022A (en)
AU (1)	AU2008224735B2 (en)
BR (1)	BRPI0808887A2 (en)
CA (1)	CA2680074C (en)
CO (1)	CO6220926A2 (en)
DK (1)	DK2131813T3 (en)
ES (1)	ES2391914T3 (en)
GB (1)	GB0704846D0 (en)
MX (1)	MX2009009758A (en)
MY (1)	MY149545A (en)
NZ (1)	NZ579895A (en)
PL (1)	PL2131813T3 (en)
PT (1)	PT2131813E (en)
RU (1)	RU2468794C2 (en)
SG (1)	SG179480A1 (en)
TW (1)	TWI367110B (en)
UA (1)	UA100509C2 (en)
WO (1)	WO2008110741A2 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TR201906789T4 (en) *	2003-11-20	2019-05-21	Novo Nordisk As	Peptide formulations containing propylene glycol that are most suitable for use in manufacturing and injection devices.
CN105218565A (en)	2008-10-17	2016-01-06	泽农医药公司	Spiral shell oxindole compounds and the purposes as therapeutical agent thereof
AR077252A1 (en)	2009-06-29	2011-08-10	Xenon Pharmaceuticals Inc	ESPIROOXINDOL COMPOUND ENANTIOMERS AND THEIR USES AS THERAPEUTIC AGENTS
MX2012004373A (en)	2009-10-14	2012-06-28	Xenon Pharmaceuticals Inc	Synthetic methods for spiro-oxindole compounds.
CA2788440A1 (en)	2010-02-26	2011-09-01	Xenon Pharmaceuticals Inc.	Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
US9271950B2 (en)	2010-10-29	2016-03-01	Infirst Healthcare Limited	Compositions for treating chronic inflammation and inflammatory diseases
US11224659B2 (en)	2010-10-29	2022-01-18	Infirst Healthcare Limited	Solid solution compositions and use in severe pain
US11202831B2 (en)	2010-10-29	2021-12-21	Infirst Healthcare Limited	Solid solution compositions and use in cardiovascular disease
US11730709B2 (en)	2010-10-29	2023-08-22	Infirst Healthcare Limited	Compositions and methods for treating severe pain
US9744132B2 (en)	2010-10-29	2017-08-29	Infirst Healthcare Limited	Solid solution compositions and use in chronic inflammation
US8895536B2 (en)	2010-10-29	2014-11-25	Infirst Healthcare Ltd.	Compositions and methods for treating chronic inflammation and inflammatory diseases
US10695432B2 (en)	2010-10-29	2020-06-30	Infirst Healthcare Limited	Solid solution compositions and use in severe pain
US10695431B2 (en)	2010-10-29	2020-06-30	Infirst Healthcare Limited	Solid solution compositions and use in cardiovascular disease
US9504664B2 (en)	2010-10-29	2016-11-29	Infirst Healthcare Limited	Compositions and methods for treating severe pain
US9737500B2 (en)	2010-10-29	2017-08-22	Infirst Healthcare Limited	Compositions and methods for treating severe pain
US9308213B2 (en)	2010-10-29	2016-04-12	Infirst Healthcare Limited	Solid solution compositions and use in chronic inflammation
EA201491854A1 (en)	2012-04-12	2015-03-31	Ксенон Фармасьютикалз Инк.	ASYMMETRIC SYNTHESIS OF SPIROXINDOL COMPOUNDS, USEFUL AS A MEDICAL TREATMENT
AU2014204739B2 (en) *	2013-01-14	2016-08-11	Infirst Healthcare Limited	Compositions and methods for treating severe pain
ES2763352T3 (en) *	2013-01-14	2020-05-28	Infirst Healthcare Ltd	Solid solution compositions and use in chronic inflammation
HK1218621A1 (en) *	2013-02-04	2017-03-03	Infirst Healthcare Limited	Compositions and methods for treating chronic inflammation and inflammatory diseases
US9012402B1 (en)	2014-06-11	2015-04-21	James Blanchard	Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
US11007161B1 (en)	2014-12-31	2021-05-18	Eric Morrison	Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10596117B1 (en)	2014-12-31	2020-03-24	Eric Morrison	Lipoleosomes as carriers for aromatic amide anesthetic compounds
US10561627B2 (en)	2014-12-31	2020-02-18	Eric Morrison	Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
TW201636017A (en)	2015-02-05	2016-10-16	梯瓦製藥國際有限責任公司	Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
GB201502845D0 (en) *	2015-02-20	2015-04-08	Futura Medical Dev Ltd	Topical pharmaceutical formulation
FR3041534B1 (en)	2015-09-30	2019-03-15	Vetoquinol Sa	ATRIAL CLEANER COMPOSITION
GB201609968D0 (en) *	2016-06-07	2016-07-20	Futura Medical Dev Ltd	Topical pharmaceutical formulation
US10100060B2 (en)	2016-06-16	2018-10-16	Xenon Pharmaceuticals Inc.	Asymmetric synthesis of funapide
JP7250689B2 (en) *	2017-03-07	2023-04-03	イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッド	Local delivery system for active compounds
US10821075B1 (en)	2017-07-12	2020-11-03	James Blanchard	Compositions for topical application of a medicaments onto a mammalian body surface
HRP20240485T1 (en)	2017-08-24	2024-07-05	Novo Nordisk A/S	Glp-1 compositions and uses thereof
PE20230819A1 (en)	2020-02-18	2023-05-19	Novo Nordisk As	COMPOSITIONS AND USES OF GLP-1
GB2596286B (en)	2020-06-20	2023-01-25	Francis Davis Adrian	Adherence to topical therapy
GB2597526A (en)	2020-07-27	2022-02-02	Incanthera R&D Ltd	Topical formulation
CN116348099B (en)	2020-07-27	2025-10-31	英加世瑞(研发)有限公司	Topical formulations
GB202012836D0 (en)	2020-08-17	2020-09-30	Futura Medical Developments Ltd	Topical composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH06104624B2 (en) *	1986-05-07	1994-12-21	太郎小木曽	Transdermal agent
PE20011092A1 (en) *	2000-02-14	2001-11-12	Procter & Gamble	COMPOSITIONS FOR THE TOPICAL DELIVERY OF A PHARMACEUTICALLY ACTIVE AGENT THAT HAS REDUCED SKIN IRRITATION
DE10019171A1 (en) *	2000-04-07	2001-10-18	Schering Ag	Compositions for use as penetration enhancers in transdermal formulations for highly lipophilic active ingredients
PE20040321A1 (en) *	2002-08-22	2004-07-15	Novartis Consumer Health Sa	TOPICAL COMPOSITION INCLUDING DICLOFENACO
US7132452B2 (en) *	2003-03-10	2006-11-07	Fang-Yu Lee	Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
WO2005027977A2 (en) *	2003-09-22	2005-03-31	Agis Industries (1983) Ltd.	Diclofenac compositions for the treatment of skin disorders
EP1588697A1 (en)	2004-04-16	2005-10-26	Kurt H. Prof. Dr. Bauer	Emulsion gel for topical application of pharmaceuticals
US20050244522A1 (en)	2004-04-30	2005-11-03	Carrara Dario Norberto R	Permeation enhancer comprising genus Curcuma or germacrone for transdermal and topical administration of active agents

2007
- 2007-03-13 GB GBGB0704846.5A patent/GB0704846D0/en not_active Ceased
2008
- 2008-02-15 RU RU2009136228/15A patent/RU2468794C2/en active
- 2008-02-15 MX MX2009009758A patent/MX2009009758A/en active IP Right Grant
- 2008-02-15 CN CN200880007936A patent/CN101663022A/en active Pending
- 2008-02-15 ES ES08709428T patent/ES2391914T3/en active Active
- 2008-02-15 NZ NZ579895A patent/NZ579895A/en not_active IP Right Cessation
- 2008-02-15 EP EP12154983A patent/EP2452671A2/en not_active Withdrawn
- 2008-02-15 UA UAA200910111A patent/UA100509C2/en unknown
- 2008-02-15 WO PCT/GB2008/000540 patent/WO2008110741A2/en not_active Ceased
- 2008-02-15 BR BRPI0808887-0A patent/BRPI0808887A2/en not_active Application Discontinuation
- 2008-02-15 PL PL08709428T patent/PL2131813T3/en unknown
- 2008-02-15 MY MYPI20093774A patent/MY149545A/en unknown
- 2008-02-15 CA CA2680074A patent/CA2680074C/en active Active
- 2008-02-15 SG SG2012017497A patent/SG179480A1/en unknown
- 2008-02-15 US US12/530,960 patent/US8541470B2/en active Active
- 2008-02-15 AU AU2008224735A patent/AU2008224735B2/en not_active Ceased
- 2008-02-15 DK DK08709428.0T patent/DK2131813T3/en active
- 2008-02-15 PT PT08709428T patent/PT2131813E/en unknown
- 2008-02-15 EP EP08709428A patent/EP2131813B1/en not_active Not-in-force
- 2008-02-15 JP JP2009553196A patent/JP2010521442A/en active Pending
- 2008-02-20 TW TW097105840A patent/TWI367110B/en not_active IP Right Cessation
2009
- 2009-10-08 CO CO09111579A patent/CO6220926A2/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2008110741A2 (en)	2008-09-18
CA2680074C (en)	2016-07-12
NZ579895A (en)	2012-02-24
DK2131813T3 (en)	2012-10-29
EP2131813A2 (en)	2009-12-16
RU2468794C2 (en)	2012-12-10
UA100509C2 (en)	2013-01-10
AU2008224735B2 (en)	2013-04-18
AU2008224735A1 (en)	2008-09-18
EP2452671A2 (en)	2012-05-16
US8541470B2 (en)	2013-09-24
CA2680074A1 (en)	2008-09-18
SG179480A1 (en)	2012-04-27
BRPI0808887A2 (en)	2014-09-02
WO2008110741A3 (en)	2009-03-12
US20100099767A1 (en)	2010-04-22
TW200836769A (en)	2008-09-16
CN101663022A (en)	2010-03-03
TWI367110B (en)	2012-07-01
PT2131813E (en)	2012-10-31
WO2008110741A8 (en)	2009-11-19
ES2391914T3 (en)	2012-12-03
RU2009136228A (en)	2011-04-20
MX2009009758A (en)	2009-09-24
EP2131813B1 (en)	2012-08-08
CO6220926A2 (en)	2010-11-19
JP2010521442A (en)	2010-06-24
MY149545A (en)	2013-09-13
PL2131813T3 (en)	2012-11-30

Legal Events

Date	Code	Title	Description
2008-11-05	AT	Applications terminated before publication under section 16(1)

Publication	Publication Date	Title
TWI367110B (en)	2012-07-01	Topical pharmaceutical formulation
HUS1800043I1 (en)	2018-11-28	Pharmaceutical formulation 514
GB2450753B (en)	2012-07-18	New Pharmaceutical formulation
HUS1800007I1 (en)	2018-03-28	Pharmaceutical composition
GB0709513D0 (en)	2007-06-27	Topical formulations
EP2133095A4 (en)	2012-09-26	Pharmaceutical composition
EP2133094A4 (en)	2010-10-13	Pharmaceutical composition
IL200125A0 (en)	2010-04-15	Pharmaceutical composition
SI2344130T1 (en)	2013-12-31	Pharmaceutical topical compositions
PL2965752T3 (en)	2025-12-08	Pharmaceutical formulation comprising ezetimibe
EP2224805A4 (en)	2013-10-16	Pharmaceutical composition
EP2224915A4 (en)	2014-01-22	Pharmaceutical composition
EP2224808A4 (en)	2013-11-27	Pharmaceutical composition
GB0614586D0 (en)	2006-08-30	Pharmaceutical Formulation
IL208788A (en)	2016-05-31	Solid pharmaceutical formulation
EP2211847A4 (en)	2013-10-02	Controlled-release pharmaceutical formulation
EP2097074A4 (en)	2013-05-01	Topical pharmaceutical composition
EP2275092A4 (en)	2013-05-01	Taxane pharmaceutical formulation
EP2124938A4 (en)	2010-04-14	Topical formulation
EP2310022A4 (en)	2011-08-24	Topical medicament
IL205975A0 (en)	2010-11-30	Pharmaceutical composition
IL205931A0 (en)	2010-11-30	Pharmaceutical composition
GB0612556D0 (en)	2006-08-02	Topical pharmaceutical formulations
GB0603151D0 (en)	2006-03-29	Topical pharmaceutical formulation
GB0713366D0 (en)	2007-08-22	Topical formulation